A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan®) in the treatment of patients with congestive heart failure NYHA II
- 1 January 2003
- journal article
- clinical trial
- Published by Elsevier in Phytomedicine
- Vol. 10 (5), 363-369
- https://doi.org/10.1078/0944-7113-00312
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Clinical efficacy of Crataegus extract WS 1442 in congestive heart failure NYHA class IIPhytomedicine, 2001
- Prognostic Value of Treadmill Exercise TestingCirculation, 1998
- Efficacy of the Hawthorn (Crataegus) preparation LI 132 in 78 patients with chronic congestive heart failure defined as NYHA functional class IIPhytomedicine, 1994
- Crataegus, Toxikologie und PharmakologiePlanta Medica, 1981
- Crataegus, Toxikologie und Pharmakologie Teil II: PharmakodynamikPlanta Medica, 1981
- Crataegus, Toxikologie und Pharmakologie*,** Teil I: ToxizitätPlanta Medica, 1981